RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > 2020 > 7 > 13 Earned Regulatory Affairs Certification (RAC) in midst of COVID-19 pandemic; Many others opt for

13 Earned Regulatory Affairs Certification (RAC) in midst of COVID-19 pandemic; Many others opt for future test date

Posted 28 July 2020 | By Zachary Brousseau 

13 Earned Regulatory Affairs Certification (RAC) in midst of COVID-19 pandemic; Many others opt for future test date

Thirteen individuals passed the Regulatory Affairs Certification (RAC) exam during the recent spring exam period, RAPS announced today. More than 90% of those who had initially registered to take the exam in the spring transferred to a later exam period, as most RAC test centers were forced to close temporarily in response to the COVID-19 pandemic. Nearly all registrants opted to take the exam at some point, rather than cancelling.

In May, RAPS announced a pilot program to allow RAC candidates to take the exam online with live online proctoring this summer. While most of the 1,000+ test sites have reopened, the pilot allows applicants the opportunity to take the exam this summer even if they cannot travel to a testing center or have a testing center nearby that remains closed.

“The COVID-19 pandemic understandably hindered many regulatory professionals’ ability to take the RAC exam this spring, but the regulatory affairs knowledge and competencies that the exam is designed to test are now more relevant than ever,” said RAPS Interim Executive Director Bill McMoil. “Regulatory professionals are key players in making safe and effective healthcare products available to the public. Current efforts to fast track development of COVID-19 treatments underscore how important their work is.”

RAC candidates may choose from two product-sector-based exams—RAC Drugs and RAC Devices—covering regulations for pharmaceuticals and medical devices, respectively. Passing requires essential knowledge of not only the regulations pertaining to either drugs or devices. It also requires the critical thinking and analytical skills to understand how they apply in various real-world situations. Practice and experience are required to guide these products through the approval process of the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and other global regulatory agencies.

The 13 individuals who passed the exam in spring 2020 now hold the highly regarded RAC credential, which serves as the leading professional credential for individuals in the healthcare product regulatory field. To stay current, the credential must be recertified every three years by demonstrating continuous learning, professional development, regulatory leadership and an overall ongoing commitment to the profession. There are currently more than 4,700 RAC-credentialed professionals around the world.

The autumn 2020 RAC exam period will be 2 November to 11 December. Registration is now open, and the deadline to apply is 8 October. For more information, visit RAPS.org/rac.

Following is the list of those who earned the RAC credential in spring 2020. Congratulations!
 
RAC Devices
Melissa Buydash Rosko
Jing Dong
Azzurra Grassi
Audrey Hinderer
Xuejun Liu
Pamela Nge
 
RAC Drugs
Rory Bales
Chiapei Chen
Sumi Choi
Nataliya Kuras
Allison Schaefer
Aimee Weber
Hyunjoung Yang

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe